These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2524413)

  • 1. Evaluation of the pancreatic B-cell function in the rat after prenatal exposure to streptozotocin or N-nitrosomethylurea.
    Serradas P; Giroix MH; Portha B
    Diabete Metab; 1989; 15(1):30-7. PubMed ID: 2524413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
    Serradas P; Bailbé D; Portha B
    Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure of pancreatic islets to different alkylating agents decreases mitochondrial DNA content but only streptozotocin induces long-lasting functional impairment of B-cells.
    Eizirik DL; Sandler S; Ahnström G; Welsh M
    Biochem Pharmacol; 1991 Nov; 42(12):2275-82. PubMed ID: 1837218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effects of streptozotocin, N-methylnitrosourea and alloxan on isolated islets of Langerhans.
    Akpan JO; Wright PH; Dulin WE
    Diabete Metab; 1987 Apr; 13(2):122-8. PubMed ID: 2954869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 1-methyl-1-nitrosourea and streptozotocin on glucose-induced insulin secretion by isolated islets of Langerhans.
    Golden P; Baird L; Malaisse WJ; Malaisse-Lagae F; Walker MM
    Diabetologia; 1976 Jul; 12(3):207-9. PubMed ID: 133846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of streptozotocin in vitro on proinsulin biosynthesis, insulin release and ATP content of isolated rat islets of Langerhans.
    Maldonato A; Trueheart PA; Renold AE; Sharp GW
    Diabetologia; 1976 Oct; 12(5):471-81. PubMed ID: 135704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Destruction of pancreatic beta cells in rats by complete Freund's adjuvant combined with non-diabetogenic doses of streptozotocin.
    Kohnert KD; Odselius R; Fält K; Ziegler B; Ziegler M; Falkmer S
    Diabetes Res; 1987 May; 5(1):1-11. PubMed ID: 2957141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro restoration of insulin production in islets from adult rats treated neonatally with streptozotocin.
    Welsh N; Hellerström C
    Endocrinology; 1990 Apr; 126(4):1842-8. PubMed ID: 2138533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetogenic effects of N-nitrosomethylurea in rats.
    Voss C; Herrmann I; Hartmann K; Zühlke H; Besch W; Keilacker H
    Exp Clin Endocrinol; 1988 Sep; 92(1):25-31. PubMed ID: 3068065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term in vitro effects of streptozotocin, interleukin-1, and high glucose concentration on the activity of mitochondrial dehydrogenases and the secretion of insulin in pancreatic islets.
    Rasschaert J; Eizirik DL; Malaisse WJ
    Endocrinology; 1992 Jun; 130(6):3522-8. PubMed ID: 1534541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal rat islet insulin deficiency following maternal administration of streptozotocin.
    Hayek A; Barela TD; Wogenrich FJ; Guardian CM
    Proc Soc Exp Biol Med; 1985 Nov; 180(2):209-13. PubMed ID: 2931727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery in the fetal pancreatic islet following fetal administration of streptozotocin in the rat in vivo and in vitro.
    Yamamoto M; Yasuda M; Hori A; Arishima K; Eguchi Y
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1319-25. PubMed ID: 15515161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of insulin biosynthesis by alloxan, streptozotocin, and N-nitrosomethylurea.
    Gunnarsson R
    Mol Pharmacol; 1975 Nov; 11(6):759-65. PubMed ID: 128691
    [No Abstract]   [Full Text] [Related]  

  • 14. Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro.
    Sandler S; Bendtzen K; Eizirik DL; Welsh M
    Endocrinology; 1990 Feb; 126(2):1288-94. PubMed ID: 2404746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic effects of streptozotocin and N-nitrosomethylurea on the pancreatic B cells with special regard to the role of nicotinamide-adenine dinucleotide.
    Gunnarsson R; Berne C; Hellerström C
    Biochem J; 1974 Jun; 140(3):487-94. PubMed ID: 4374939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of glucose-induced insulin release during the spontaneous remission of streptozocin diabetes induced in the newborn rat.
    Portha B; Kergoat M
    Diabetes; 1985 Jun; 34(6):574-9. PubMed ID: 3891470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of streptozotocin added in vitro on insulin biosynthesis and release in isolated rat islets.
    Maldonato A; Trueheart P; Renold AE
    Horm Metab Res; 1976; Suppl 6():71-3. PubMed ID: 132395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptozotocin-induced elevation of pancreatic taurine content and suppressive effect of taurine on insulin secretion.
    Tokunaga H; Yoneda Y; Kuriyama K
    Eur J Pharmacol; 1983 Feb; 87(2-3):237-43. PubMed ID: 6220915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyproheptadine metabolites inhibit proinsulin and insulin biosynthesis and insulin release in isolated rat pancreatic islets.
    Chow SA; Falany JL; Fischer LJ
    Cell Biol Toxicol; 1989 Jun; 5(2):129-43. PubMed ID: 2670085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection by thymidine, an inhibitor of polyadenosine diphosphate ribosylation, of streptozotocin inhibition of insulin secretion.
    Bolaffi JL; Nagamatsu S; Harris J; Grodsky GM
    Endocrinology; 1987 May; 120(5):2117-22. PubMed ID: 2952491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.